A Novel Glycolysis and Hypoxia Combined Gene Signature Predicts the Prognosis and Affects Immune Infiltration of Patients with Colon Cancer.

Guochao MaoJianhua WuHanxiao CuiLuyao DaiLi MaZhangjian ZhouBaobao LiangShuqun ZhangShuai Lin

Published in: International journal of general medicine (2022)

A glycolysis and hypoxia combined gene signature was a promising method to evaluate the prognosis and immune infiltration of colon cancer patients, which may provide a new tool for cancer management.

Keyphrases

end stage renal disease
newly diagnosed
copy number
genome wide
endothelial cells
ejection fraction
genome wide identification
gene expression
squamous cell carcinoma
squamous cell
transcription factor
patient reported
genome wide analysis